Logo image of NEXT.OL

NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Fundamental Analysis

OSL:NEXT - Euronext Oslo - NO0010629108 - Common Stock - Currency: NOK

5.96  +0.16 (+2.76%)

Fundamental Rating

2

NEXT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 49 industry peers in the Electronic Equipment, Instruments & Components industry. NEXT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NEXT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NEXT has reported negative net income.
NEXT had a negative operating cash flow in the past year.
NEXT had negative earnings in each of the past 5 years.
In the past 5 years NEXT always reported negative operating cash flow.
NEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFNEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

NEXT has a Return On Assets of -24.68%. This is amonst the worse of the industry: NEXT underperforms 83.67% of its industry peers.
The Return On Equity of NEXT (-31.26%) is worse than 75.51% of its industry peers.
Industry RankSector Rank
ROA -24.68%
ROE -31.26%
ROIC N/A
ROA(3y)-39.33%
ROA(5y)-46.51%
ROE(3y)-49.73%
ROE(5y)-59.73%
ROIC(3y)N/A
ROIC(5y)N/A
NEXT.OL Yearly ROA, ROE, ROICNEXT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

NEXT's Gross Margin of 54.95% is fine compared to the rest of the industry. NEXT outperforms 73.47% of its industry peers.
NEXT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NEXT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.94%
GM growth 5Y17.67%
NEXT.OL Yearly Profit, Operating, Gross MarginsNEXT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

6

2. Health

2.1 Basic Checks

NEXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEXT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NEXT has more shares outstanding
NEXT has a worse debt/assets ratio than last year.
NEXT.OL Yearly Shares OutstandingNEXT.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly Total Debt VS Total AssetsNEXT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 12.26 indicates that NEXT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.26, NEXT belongs to the top of the industry, outperforming 95.92% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that NEXT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, NEXT belongs to the top of the industry, outperforming 91.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 12.26
ROIC/WACCN/A
WACC8.51%
NEXT.OL Yearly LT Debt VS Equity VS FCFNEXT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

2.3 Liquidity

A Current Ratio of 4.84 indicates that NEXT has no problem at all paying its short term obligations.
NEXT has a better Current ratio (4.84) than 95.92% of its industry peers.
A Quick Ratio of 4.27 indicates that NEXT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.27, NEXT belongs to the top of the industry, outperforming 95.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.84
Quick Ratio 4.27
NEXT.OL Yearly Current Assets VS Current LiabilitesNEXT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.02% over the past year.
Looking at the last year, NEXT shows a very strong growth in Revenue. The Revenue has grown by 109.29%.
Measured over the past years, NEXT shows a decrease in Revenue. The Revenue has been decreasing by -3.15% on average per year.
EPS 1Y (TTM)48.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.25%
Revenue 1Y (TTM)109.29%
Revenue growth 3Y12.34%
Revenue growth 5Y-3.15%
Sales Q2Q%-7.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEXT.OL Yearly Revenue VS EstimatesNEXT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly EPS VS EstimatesNEXT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NEXT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEXT.OL Price Earnings VS Forward Price EarningsNEXT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEXT.OL Per share dataNEXT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NEXT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXT BIOMETRICS GROUP AS

OSL:NEXT (3/7/2025, 7:00:00 PM)

5.96

+0.16 (+2.76%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-19 2025-02-19
Earnings (Next)05-14 2025-05-14
Inst Owners6.05%
Inst Owner ChangeN/A
Ins Owners6.59%
Ins Owner ChangeN/A
Market Cap686.29M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.54
P/FCF N/A
P/OCF N/A
P/B 5.49
P/tB 5.53
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.62
BVpS1.08
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.68%
ROE -31.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM N/A
ROA(3y)-39.33%
ROA(5y)-46.51%
ROE(3y)-49.73%
ROE(5y)-59.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.94%
GM growth 5Y17.67%
F-Score4
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.6%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.84
Quick Ratio 4.27
Altman-Z 12.26
F-Score4
WACC8.51%
ROIC/WACCN/A
Cap/Depr(3y)3.92%
Cap/Depr(5y)3.04%
Cap/Sales(3y)0.33%
Cap/Sales(5y)0.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)109.29%
Revenue growth 3Y12.34%
Revenue growth 5Y-3.15%
Sales Q2Q%-7.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.61%
OCF growth 3YN/A
OCF growth 5YN/A